ARTICLE | Company News
Harbour Antibodies, Shang Pharma deal
September 17, 2012 7:00 AM UTC
ShangPharma will use Harbour's human immunoglobulin-gene transgenic mice for human antibody development services. The mice produce IgG antibodies with human variable regions. The companies could not b...